BSE Live
Feb 23, 16:00Prev. Close
317.40
Open Price
315.55
Bid Price (Qty.)
301.00 (87)
Offer Price (Qty.)
302.30 (1)
NSE Live
Feb 23, 15:51Prev. Close
316.10
Open Price
316.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
302.30 (302)
| Key Financial Ratios of Medicamen Biotech (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 1.83 | 0.60 | |
| Diluted EPS (Rs.) | 1.83 | 0.60 | |
| Cash EPS (Rs.) | 2.66 | 1.27 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 9.16 | 7.33 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 9.16 | 7.33 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 62.30 | 63.17 | |
| PBDIT/Share (Rs.) | 3.74 | 2.14 | |
| PBIT/Share (Rs.) | 2.98 | 1.53 | |
| PBT/Share (Rs.) | 2.13 | 0.74 | |
| Net Profit/Share (Rs.) | 1.83 | 0.60 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 6.00 | 3.38 | |
| PBIT Margin (%) | 4.78 | 2.42 | |
| PBT Margin (%) | 3.42 | 1.17 | |
| Net Profit Margin (%) | 2.93 | 0.94 | |
| Return on Networth / Equity (%) | 19.97 | 8.16 | |
| Return on Capital Employed (%) | 11.74 | 4.13 | |
| Return on Assets (%) | 4.88 | 1.70 | |
| Total Debt/Equity (X) | 1.26 | 1.78 | |
| Asset Turnover Ratio (%) | 166.20 | 179.63 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.15 | 1.15 | |
| Quick Ratio (X) | 0.92 | 0.79 | |
| Inventory Turnover Ratio (X) | 12.60 | 8.68 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 100.00 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 18.26 | 15.49 | |
| EV/Net Operating Revenue (X) | 0.38 | 0.32 | |
| EV/EBITDA (X) | 6.32 | 9.37 | |
| MarketCap/Net Operating Revenue (X) | 0.22 | 0.13 | |
| Retention Ratios (%) | 100.00 | 100.00 | |
| Price/BV (X) | 1.48 | 1.15 | |
| Price/Net Operating Revenue | 0.22 | 0.13 | |
| Earnings Yield | 0.13 | 0.07 |
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y